FDA Enforcement
Class II
Terminated
ZYMUTEST HIA MonoStria qualitative screening assay intended for the global detection of heparin-dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma, by clinical laboratories. p IgGAM; REF Number: RK041D; UDI: 03663537046810
Recall: Z-1743-2018
·
Reported May 16, 2018
Enforcement
- Recall Number
- Z-1743-2018
- Event ID
- 79797
- Classification
- Class II
- Status
- Terminated
- Product Type
- Devices
- Firm
- Hyphen BioMed
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Report Date
- May 16, 2018
- Initiation Date
- February 5, 2018
- Classification Date
- May 8, 2018
- Termination Date
- August 16, 2018
- Address
- 155 rue d Eragny, N/A, Neuville Sur Oise, N/A, N/A, France
Description
ZYMUTEST HIA MonoStria qualitative screening assay intended for the global detection of heparin-dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma, by clinical laboratories. p IgGAM; REF Number: RK041D; UDI: 03663537046810
Reason
Incorrect package insert indicating use of the kits with plasma, serum, and other biological fluids. The kits should only be used with plasma.
Code Info
Lot numbers: F1600568P1, F1701370P1, F1701370P2
Distribution
OH, MD, NC, NY, NH, Canada, Sweden
Quantity
60